A Phase 2 multi-center, investigator masked, 28-day, parallel group, dose-finding study of NCX-470 in adult subjects with elevated intraocular pressure (IOP) due to open-angle glaucoma or ocular hypertension
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2018
At a glance
- Drugs NCX 470 (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus First in man; Therapeutic Use
- 06 Mar 2018 According to a Nicox media release, the company plans to submit IND to the US FDA in Q1 2019
- 19 Dec 2017 According to a Nicox media release, the company plans to submit an Investigational New Drug (IND) application for NCX 470 to the US FDA in the summer of 2018.
- 24 Oct 2017 According to a Nicox media release, IND filling is anticipated in the first half of 2018.